Sucrase-isomaltase genotype and response to a starch-reduced and sucrose-reduced diet in IBS-D patients
Open Access
Abstract
To cite Zamfir-Taranu A, Löscher B-S, Husein DM, et al. Gut Epub ahead of print: [please include Day Month Year].Keywords
Funding Information
- MCIN (MCIN/AEI/10.13039/501100011033 (PID2020-113625RB-I00))
This publication has 11 references indexed in Scilit:
- The effect of starch- and sucrose-reduced diet accompanied by nutritional and culinary recommendations on the symptoms of irritable bowel syndrome patients with diarrhoeaTherapeutic Advances in Gastroenterology, 2023
- Irritable bowel syndrome: treatment based on pathophysiology and biomarkersGut, 2022
- Rome Foundation Clinical Diagnostic Criteria for Disorders of Gut-Brain InteractionGastroenterology, 2022
- The FODMAP diet: more than just a symptomatic therapy?Gut, 2021
- Rare Hypomorphic Sucrase Isomaltase Variants in Relation to Irritable Bowel Syndrome Risk in UK BiobankGastroenterology, 2021
- Adult sucrase-isomaltase deficiency masquerading as IBSGut, 2021
- Precision Nutrition and the Microbiome, Part I: Current State of the ScienceNutrients, 2019
- Reduced efficacy of low FODMAPs diet in patients with IBS-D carrying sucrase-isomaltase ( SI ) hypomorphic variantsGut, 2019
- Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome PatientsClinical Gastroenterology and Hepatology, 2018
- Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndromeGut, 2016